Pharmaceutical TechnologyOriginal article
EMA validates Pfizer and Valneva’s Lyme disease vaccine
RegulatoryPF-07307405Positive
AI Analysis
Summary
The EMA has validated the marketing authorization application from Pfizer and Valneva for their Lyme disease vaccine candidate PF-07307405. This regulatory milestone advances the vaccine toward potential European approval.
Outcome Details
EMA validated marketing authorization application
Importance:6/10
Sentiment:
0.70
EMAvaccineregulatory approvalLyme diseasemarketing authorization
Read the original article
Published by Pharmaceutical Technology on August 17, 2026 9:20 AM